These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22995475)

  • 1. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
    Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
    Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
    Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
    Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
    Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
    J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
    Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
    Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
    Jin Q; Gao G; Mulder KM
    J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
    Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
    BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ΔNp63 bookmarks and creates an accessible epigenetic environment for TGFβ-induced cancer cell stemness and invasiveness.
    Vasilaki E; Bai Y; Ali MM; Sundqvist A; Moustakas A; Heldin CH
    Cell Commun Signal; 2024 Aug; 22(1):411. PubMed ID: 39180088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway.
    Li Q; Liu X; Zhao C
    J Cell Biochem; 2019 Sep; 120(9):15098-15105. PubMed ID: 31131472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.
    Chen X; Cao X; Sun X; Lei R; Chen P; Zhao Y; Jiang Y; Yin J; Chen R; Ye D; Wang Q; Liu Z; Liu S; Cheng C; Mao J; Hou Y; Wang M; Siebenlist U; Eugene Chin Y; Wang Y; Cao L; Hu G; Zhang X
    Cell Death Dis; 2016 Dec; 7(12):e2508. PubMed ID: 27906182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of TGFβ/Smad signaling by the small GTPase RhoB.
    Livitsanou M; Vasilaki E; Stournaras C; Kardassis D
    Cell Signal; 2018 Aug; 48():54-63. PubMed ID: 29705334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.
    Simonsson M; Kanduri M; Grönroos E; Heldin CH; Ericsson J
    J Biol Chem; 2006 Dec; 281(52):39870-80. PubMed ID: 17074756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner.
    Nye MD; Almada LL; Fernandez-Barrena MG; Marks DL; Elsawa SF; Vrabel A; Tolosa EJ; Ellenrieder V; Fernandez-Zapico ME
    J Biol Chem; 2014 May; 289(22):15495-506. PubMed ID: 24739390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.
    Martin BT; Kleiber K; Wixler V; Raab M; Zimmer B; Kaufmann M; Strebhardt K
    Cell Cycle; 2007 Jul; 6(14):1779-88. PubMed ID: 17682292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.